IOL CHEMICALS AND PHARMACEUTICALS LTD.

NSE : IOLCPBSE : 524164ISIN CODE : INE485C01011Industry : Pharmaceuticals & DrugsHouse : Trident
BSE399.500.45 (+0.11 %)
PREV CLOSE ( ) 399.05
OPEN PRICE ( ) 398.25
BID PRICE (QTY) 0.00 (0)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 24133
TODAY'S LOW / HIGH ( )394.00 405.05
52 WK LOW / HIGH ( )350.3 535.6
NSE399.50-0.85 (-0.21 %)
PREV CLOSE( ) 400.35
OPEN PRICE ( ) 402.90
BID PRICE (QTY) 399.50 (746)
OFFER PRICE (QTY) 0.00 (0)
VOLUME 175229
TODAY'S LOW / HIGH( ) 394.10 405.00
52 WK LOW / HIGH ( )350.55 535.9
( in Million)
Select year
ParticularsMar2023Mar2022
Profit Before Tax1886.502248.50
Adjustment444.10331.20
Changes In working Capital-636.90-1023.40
Cash Flow after changes in Working Capital1693.701556.30
Cash Flow from Operating Activities1222.70930.50
Cash Flow from Investing Activities-1200.00-1205.20
Cash Flow from Financing Activities-41.10-16.40
Net Cash Inflow / Outflow-18.40-291.10
Opening Cash & Cash Equivalents32.30323.40
Cash & Cash Equivalent on Amalgamation / Take over / MergerNANA
Cash & Cash Equivalent of Subsidiaries under liquidationsNANA
Translation adjustment on reserves / op cash balalces frgn subsidiariesNANA
Effect of Foreign Exchange FluctuationsNANA
Closing Cash & Cash Equivalent13.9032.30

© NIRMAL BANG. All rights reserved

Designed , Developed & Content Powered by Accord Fintech Pvt. Ltd.

Open an Account
FOR AFREE *DEMAT & BROKING ACCOUNT

Please fill in the details below

Close X

(Note - You will receive a call from our sales executive)

CLOSE X

RISK DISCLOSURES ON DERIVATIVES

  • 9 out of 10 individual traders in equity Futures and Options Segment, incurred net losses.
  • On an average, loss makers registered net trading loss close to ₹ 50,000.
  • Over and above the net trading losses incurred, loss makers expended an additional 28% of net trading losses as transaction costs.
  • Those making net trading profits, incurred between 15% to 50% of such profits as transaction cost.

Source:

1. SEBI study dated January 25, 2023 on “Analysis of Profit and Loss of Individual Traders dealing in equity Futures and Options (F&O) Segment”, wherein Aggregate Level findings are based on annual Profit/Loss incurred by individual traders in equity F&O during FY 2021-22.